- cypherpunks-legacy - lists.cpunks.org

New Breed of St0-ck Trader
by Edith Lund 13 Jun '05

13 Jun '05

SmallCap BIOTECH Report <> STEM CELL <> CRYOGENICS <> STEM CELL <> INVESTING IN EMERGING BIOTECH STOCKS :: COMPANY SPOTLIGHT ::. Bio-Matrix Scientific Group Inc. Driving $75 billion dollar a year Biotechnology and Medical Device industries is the demand for new products that improve patient safety, decrease healthcare cost, and most importantly enhance human life. Symbol: BMXP Trading Price: $0.94 About Bio-Matrix Scientific Group Inc.: Bio-Matrix Scientific Group Inc. is a San Diego based development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Its polymer coating on medical devices will ensure that cell transference is done with minimal damage to cells. This should lead to better yields in stem cell extraction, along with better outcomes for patients in tissue management procedures. Recent News: A spokesperson for the Company said that its Board of Directors plans to spin-off 6,035,501 shares of the common stock of Frezer, Inc., a wholly owned subsidiary of Bio-Matrix Scientific Group, to BMXP shareholders of record as of May 31, 2OO5. This represents one share of Frezer, Inc. for every one share of Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) owned post reverse split. "Ground floor" Company Enters Production Phase Bio-Matrix Scientific Group Inc., announced that Collective Technologies will manufacture Bio-Matrix's first set of Stem Cell Devices. The Company anticipates having this set of instruments sometime within the next two weeks. BMXP also recently finalized applications for 3 new devices. This is the first step towards full production of these devices. This first set of devices will be used for its 51O(k) testing, trade shows and presentations to Physicians and Researchers. "Collective Technologies enables us to manufacture products in the most efficient and cost-effective way possible," noted Brian Pockett, Managing Director and COO of Bio-Matrix Scientific. "We have been impressed by Collective Technologies' quality record, responsiveness and flexibility - all of which are critical to our production objectives." Bio-Matrix sees this event as nearing a point at which the Company "green-lights" full production of its stem cell and tissue management instruments. "REAL DEAL" MANAGEMENT Philip Watts, Ph.D., the Company's Director of Research and Development, highly recognized in his field. James L. Lambert, Ph.D., as its Bio-Instrument Scientific Advisor. Dr. Lambert specializes in the development of next generation bio-instrumentation for use in medical research. Dr. Lambert has been with the Jet Propulsion Laboratory for 17 years, and for the last five years he has served as the Technical Group Supervisor of the Intelligent Instrument and Systems Technology Group. Dr. Lambert leads a multidisciplinary group whose members have advanced degrees in chemistry, biology, electrical engineering, and computer science. The charter of the group is to develop advanced in situ instruments and sensors for NASA and other agencies. Geoffrey O'Neill, Ph.D. President of the Company. Dr. O'Neill most recently served as Director of Stem Cell Laboratories and Scientific Research for Cryo-Cell International Inc. (OTC: CCEL). Cryo-Cell International represents themselves as the world's largest U-Cord stem cell banking firm. "The appointment of Dr. O'Neill as President of Bio-Matrix Scientific Group Inc. signals our Company's aggressive growth plans in stem cell research devices, biomedical devices and the continued growth in the development of our Stem Cell Cryogenic Banks," said Brian Pockett, Managing Director and COO of Bio-Matrix Scientific PRODUCT DEVELOPMENT Stem Cell Cryogenics Instrumentation for Stem Cell Research and Tissue Management Non-Invasive Bio-Systems Monitoring and Measuring Devices Niche Medical Device Instrumentation The Company has recently filed a provisional patent application with the U. S. Patent Office. It anticipates numerous utility patents will result from this filing. Investment Prosective: Bio-Matrix has a four pronged revenue strategy each with a different trajectory and different inflection points. The company is spreading its risk over different operating segments with varying investment requirement and levels of risk. Larger companies in the medical device industry are aggressive and smaller companies are always takeover targets. Potential of BMXP: The market size of the segments it has chosen to operate in is huge. The tissue management instruments market size alone is $86O million. A provisional patent application has already been filed and more are in the pipeline. IMPORTANT DISCLAIMER: Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will", "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks,securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 1 we have been compensated thirty thousand dollars for the dissemination of this profile.. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company.

1 0

Powerhouse St0ck
by Royce Collins 13 Jun '05

13 Jun '05

SmallCap BIOTECH Report <> STEM CELL <> CRYOGENICS <> STEM CELL <> INVESTING IN EMERGING BIOTECH STOCKS :: COMPANY SPOTLIGHT ::. Bio-Matrix Scientific Group Inc. Driving $75 billion dollar a year Biotechnology and Medical Device industries is the demand for new products that improve patient safety, decrease healthcare cost, and most importantly enhance human life. Symbol: BMXP Trading Price: $0.94 About Bio-Matrix Scientific Group Inc.: Bio-Matrix Scientific Group Inc. is a San Diego based development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Its polymer coating on medical devices will ensure that cell transference is done with minimal damage to cells. This should lead to better yields in stem cell extraction, along with better outcomes for patients in tissue management procedures. Recent News: A spokesperson for the Company said that its Board of Directors plans to spin-off 6,035,501 shares of the common stock of Frezer, Inc., a wholly owned subsidiary of Bio-Matrix Scientific Group, to BMXP shareholders of record as of May 31, 2005. This represents one share of Frezer, Inc. for every one share of Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) owned post reverse split. "Ground floor" Company Enters Production Phase Bio-Matrix Scientific Group Inc., announced that Collective Technologies will manufacture Bio-Matrix's first set of Stem Cell Devices. The Company anticipates having this set of instruments sometime within the next two weeks. BMXP also recently finalized applications for 3 new devices. This is the first step towards full production of these devices. This first set of devices will be used for its 510(k) testing, trade shows and presentations to Physicians and Researchers. "Collective Technologies enables us to manufacture products in the most efficient and cost-effective way possible," noted Brian Pockett, Managing Director and COO of Bio-Matrix Scientific. "We have been impressed by Collective Technologies' quality record, responsiveness and flexibility - all of which are critical to our production objectives." Bio-Matrix sees this event as nearing a point at which the Company "green-lights" full production of its stem cell and tissue management instruments. "REAL DEAL" MANAGEMENT Philip Watts, Ph.D., the Company's Director of Research and Development, highly recognized in his field. James L. Lambert, Ph.D., as its Bio-Instrument Scientific Advisor. Dr. Lambert specializes in the development of next generation bio-instrumentation for use in medical research. Dr. Lambert has been with the Jet Propulsion Laboratory for 17 years, and for the last five years he has served as the Technical Group Supervisor of the Intelligent Instrument and Systems Technology Group. Dr. Lambert leads a multidisciplinary group whose members have advanced degrees in chemistry, biology, electrical engineering, and computer science. The charter of the group is to develop advanced in situ instruments and sensors for NASA and other agencies. Geoffrey O'Neill, Ph.D. President of the Company. Dr. O'Neill most recently served as Director of Stem Cell Laboratories and Scientific Research for Cryo-Cell International Inc. (OTC: CCEL). Cryo-Cell International represents themselves as the world's largest U-Cord stem cell banking firm. "The appointment of Dr. O'Neill as President of Bio-Matrix Scientific Group Inc. signals our Company's aggressive growth plans in stem cell research devices, biomedical devices and the continued growth in the development of our Stem Cell Cryogenic Banks," said Brian Pockett, Managing Director and COO of Bio-Matrix Scientific PRODUCT DEVELOPMENT Stem Cell Cryogenics Instrumentation for Stem Cell Research and Tissue Management Non-Invasive Bio-Systems Monitoring and Measuring Devices Niche Medical Device Instrumentation The Company has recently filed a provisional patent application with the U. S. Patent Office. It anticipates numerous utility patents will result from this filing. Investment Prosective: Bio-Matrix has a four pronged revenue strategy each with a different trajectory and different inflection points. The company is spreading its risk over different operating segments with varying investment requirement and levels of risk. Larger companies in the medical device industry are aggressive and smaller companies are always takeover targets. Potential of BMXP: The market size of the segments it has chosen to operate in is huge. The tissue management instruments market size alone is $860 million. A provisional patent application has already been filed and more are in the pipeline. IMPORTANT DISCLAIMER: Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will", "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks,securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 1 we have been compensated thirty thousand dollars for the dissemination of this profile.. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company.

1 0

New Breed of St0-ck Trader
by Randall Vega 13 Jun '05

13 Jun '05

SmallCap BIOTECH Report <> STEM CELL <> CRYOGENICS <> STEM CELL <> INVESTING IN EMERGING BIOTECH STOCKS :: COMPANY SPOTLIGHT ::. Bio-Matrix Scientific Group Inc. Driving $75 billion dollar a year Biotechnology and Medical Device industries is the demand for new products that improve patient safety, decrease healthcare cost, and most importantly enhance human life. Symbol: BMXP Trading Price: $O.94 About Bio-Matrix Scientific Group Inc.: Bio-Matrix Scientific Group Inc. is a San Diego based development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Its polymer coating on medical devices will ensure that cell transference is done with minimal damage to cells. This should lead to better yields in stem cell extraction, along with better outcomes for patients in tissue management procedures. Recent News: A spokesperson for the Company said that its Board of Directors plans to spin-off 6,O35,501 shares of the common stock of Frezer, Inc., a wholly owned subsidiary of Bio-Matrix Scientific Group, to BMXP shareholders of record as of May 31, 20O5. This represents one share of Frezer, Inc. for every one share of Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) owned post reverse split. "Ground floor" Company Enters Production Phase Bio-Matrix Scientific Group Inc., announced that Collective Technologies will manufacture Bio-Matrix's first set of Stem Cell Devices. The Company anticipates having this set of instruments sometime within the next two weeks. BMXP also recently finalized applications for 3 new devices. This is the first step towards full production of these devices. This first set of devices will be used for its 51O(k) testing, trade shows and presentations to Physicians and Researchers. "Collective Technologies enables us to manufacture products in the most efficient and cost-effective way possible," noted Brian Pockett, Managing Director and COO of Bio-Matrix Scientific. "We have been impressed by Collective Technologies' quality record, responsiveness and flexibility - all of which are critical to our production objectives." Bio-Matrix sees this event as nearing a point at which the Company "green-lights" full production of its stem cell and tissue management instruments. "REAL DEAL" MANAGEMENT Philip Watts, Ph.D., the Company's Director of Research and Development, highly recognized in his field. James L. Lambert, Ph.D., as its Bio-Instrument Scientific Advisor. Dr. Lambert specializes in the development of next generation bio-instrumentation for use in medical research. Dr. Lambert has been with the Jet Propulsion Laboratory for 17 years, and for the last five years he has served as the Technical Group Supervisor of the Intelligent Instrument and Systems Technology Group. Dr. Lambert leads a multidisciplinary group whose members have advanced degrees in chemistry, biology, electrical engineering, and computer science. The charter of the group is to develop advanced in situ instruments and sensors for NASA and other agencies. Geoffrey O'Neill, Ph.D. President of the Company. Dr. O'Neill most recently served as Director of Stem Cell Laboratories and Scientific Research for Cryo-Cell International Inc. (OTC: CCEL). Cryo-Cell International represents themselves as the world's largest U-Cord stem cell banking firm. "The appointment of Dr. O'Neill as President of Bio-Matrix Scientific Group Inc. signals our Company's aggressive growth plans in stem cell research devices, biomedical devices and the continued growth in the development of our Stem Cell Cryogenic Banks," said Brian Pockett, Managing Director and COO of Bio-Matrix Scientific PRODUCT DEVELOPMENT Stem Cell Cryogenics Instrumentation for Stem Cell Research and Tissue Management Non-Invasive Bio-Systems Monitoring and Measuring Devices Niche Medical Device Instrumentation The Company has recently filed a provisional patent application with the U. S. Patent Office. It anticipates numerous utility patents will result from this filing. Investment Prosective: Bio-Matrix has a four pronged revenue strategy each with a different trajectory and different inflection points. The company is spreading its risk over different operating segments with varying investment requirement and levels of risk. Larger companies in the medical device industry are aggressive and smaller companies are always takeover targets. Potential of BMXP: The market size of the segments it has chosen to operate in is huge. The tissue management instruments market size alone is $860 million. A provisional patent application has already been filed and more are in the pipeline. IMPORTANT DISCLAIMER: Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will", "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks,securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with Section 1 we have been compensated thirty thousand dollars for the dissemination of this profile.. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company.

1 0

Powerhouse st0ck Profiles
by enftfhk＠divewaikiki.com 13 Jun '05

13 Jun '05

ROCKET ST0CKS NEWSLETTER First we would like to say Thank You to all of our avid readers! We have had HUGE success over the last few months and have become one of the most widely read investment newsletters in the world. We have accomplished this by providing timely, accurate information on ST0CKS with the potential for great returns. Rocket ST0CKS is not your father's investment newsletter! We focus on ST0CKS with the potential to go up in value by well over 500%. That's what it takes to make it on to our list. These are ST0CKS for the risk tolerant investor! The beauty of this is that it only takes one smart investment to make serious profits! Investors, let's MAKE MONEY! Here's our next HOT PICK! New Developments Expected To Move Western Sierra Mining, Inc. St0ck >From $ O.80 To Over $ 5.OO Symbol: WSRM.PK Current Price: $0.65 Short Term Target Price: $4.60 12 month Target Price: $8.90 westernsierramining. com All it takes is one breakthrough, one fortunate turn of events, one BIG contract, and the stock of a small company such as this can Explode! Western Sierra Mining is a company on the move, fast! Big news is out! Big business is afoot for WSRM! Read on to find out why WSRM is our TOP pick this week. ***NEWS FROM THE INDUSTRY*** * Mining ST0CKS have outperformed both the S&P 5OO and the Dow Jones Industrial Average over the last three years. * Profits by mining companies have doubled for the second year in a row. Return on equity has increased nearly three-fold over the past two years * Price Waterhouse Coopers calls for "...another bumper year for the global mining industry in 2O05." They go on to say, "The sustained upturn in commodity prices has caught investors' attention, creating a dash for mining ST0CKS. Add the unprecedented profits and free cash flows and we have a very buoyant industry." For more information read, Mine - Enter the Dragon, by Price Waterhouse Coopers, located at PWCglobal.com ***TOP REASONS TO CONSIDER WSRM*** * Western Sierra Mining has a very profitable business model in which they avoid the highest cost associate with mining: Exploration. Essentially, Wester Sierra operates mines on sites that have been previously explored and found to be "too small" for the largest mining companies, yet still produce handsome profits. * The global mining industry boom will continue for the foreseeable future due to the impact of China-driven demand on commodity prices and long supply-response lead times. * News! News! News! Read on to find out why we expect WSRM to take off this week! HERE IS RECENT NEWS ON THE COMPANY: PHOENIX--(BUSINESS WIRE)--June 3, 20O5--Western Sierra Mining (Pink Sheets: WSRM - News) announced today that it has signed a Letter of Intent with ASDI Corp. providing WSRM the right to develop the ASDI property located in Crescent Valley at Battle Mountain, Nev. PHOENIX--(BUSINESS WIRE)--June 1O, 20O5--Western Sierra Mining (Pink Sheets: WSRM - News) and OreTech Inc. (Pink Sheets: ORTE - News) announced today that their respective boards of directors have agreed to enter into an agreement to develop the Silver Plume and Pittsburg mines located in Colorado. Commenting on the proposed transaction, the president of Western Sierra Mining, Michael Chaffee, said, "The new alignment with OreTech will allow each of the companies to utilize their specific expertise to the maximum benefit of the other. OreTech is trying to focus on developing its propriety extraction technology and Western is expanding its mining activities in the U.S. We have started our due diligence on the property and look forward to taking a proposal back to OreTech by the end of the month. "We also will pursue an agreement to use the OreTech extraction technology at the Colorado site in the event we can assure ourselves and OreTech that the values exist in Colorado at a commercial level." We cannot stress enough the significance of this news. That a small company such as this would have the rights to these rich properties speaks volumes for their management and near-future earnings. That they would be so fortunate as to be involved with an industry pioneer such as Oretech is nothing short of extraordinary. These fortuitous events have made WSRM our HOT PICK of the week! We love this company! We Believe the SPECULATIVE NEAR TERM TARGET PRICE is - $4.60 We Believe the SPECULATIVE LONG TERM TARGET PRICE is - $8.9O Please Watch this one trade Monday! DISCLAIMER: Information within this email contains "FORWARD looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "FORWARD looking statements."FORWARD looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. FORWARD looking statements in this action may be identified through the use of words such as "projects", "foresee", "expects", "will," "anticipates," "estimates," "believes," "understands" or that by statements indicating certain actions "may," "could," or "might" occur. As with many micro-cap ST0CKS, today's company has additional risk factors worth noting. Those factors include: a limited operating history, the company advancing cash to related parties and a shareholder on an unsecured basis: one vendor, a related party through a majority stockholder, supplies ninety-seven percent of the company's raw materials: reliance on two customers for over fifty percent of their business and numerous related party transactions and the need to raise capital. These factors and others are more fully spelled out in the company's SEC filings. We urge you to read the filings before you invest. The ROCKET ST0CK Report does not represent that the information contained in this message states all material facts or does not omit a material fact necessary to make the statements therein not misleading. All information provided within this email pertaining to investing, STOCKS, securities must be understood as information provided and not investment advice. The ROCKET STOCK Report advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in STOCKS featured within this email. None of the material within this report shall be construed as any kind of investment advice or solicitation. Many of these companies are on the verge of bankruptcy. You can lose all your MONEY by investing in this STOCK. The publisher of The ROCKET STOCK Report is not a registered investment ADVIS0R. Subscribers should not view information herein as legal, tax, accounting or investment advice. Any reference to past performance(s) of companies are specially selected to be referenced based on the favorable performance of these companies. You would need perfect timing to achieve the results in the examples given. There can be no assurance of that happening. Remember, as always, past performance is never indicative of future results and a thorough due diligence effort, including a review of a company's filings, should be completed prior to investing. In compliance with the Securities Act of 1933, Section 17(b), The ROCKET STOCK Report discloses the receipt of twelve thousand D0LLARS from a third party (GEM,Inc.), not an officer, director or affiliate shareholder for the circulation of this report. GEM, Inc. has a position in the STOCK they will sell at any time without notice. Be aware of an inherent conflict of interest resulting from such compensation due to the fact that this is a paid advertisement and we are conflicted. All factual information in this report was gathered from public sources, including but not limited to Company Websites, SEC Filings and Company Press Releases. The ROCKET STOCK Report believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. If you wish to stop future mailings, please mail to daily_news893 @ yahoo.com

1 0

RE: your private invitation Salvador
by Kathrine Rich 13 Jun '05

13 Jun '05

Dear Homeowner, You have been pre-approved for a $402,000 Home Loan at 3.45% Fixed Rate. This offer is being extended to you unconditionally and your credit is in no way a factor. To take Advantage of this Limited Time opportunity all we ask is that you visit our Website and complete the 1 minute post Approval Form. http://www.instant-approval.net/2/index/bvk Best Regards, Kathrine Rich Regional CEO segmentation nh damnation tym climb em concision uws crossbar sau courtney lzf bowl bj calumet kms confidante is actinometer dw http://instant-approval.net/rem.php

1 0

Prro vi-agara - We finally reach it corvallis
by Nelson Collins 12 Jun '05

12 Jun '05

As you already know, the beter and improved vi-agara flows on the market. Although it is very popular, not many online stores has it. We made huge effort in order to have it, as we know out costumers trust us and know that we're the frontline when it comes to honest priices and beter mads. This mad will acct faster, and it is more cheeper. http://gkmabfce.allthemeds.info/?dhijlcexwvqsygkmzvpabf jonny k of ny says outstanding! the tarpon flies are sharp the neerly liv e pinfish look great the glades minnows look like mike conner s original design everything is sharp. echt een leuke site heb enorm genoten zal je nog wat mooie mannen sturen voor je site groetjes en kusjes magydy. i used to live in esperance miss it sooooo ooo much!!! i love it! love ya bye!!!! xxxooo. leuke brandweer site! behalve in miniatuur heb ik niet veel met de brandweer te maken gelukkig. click the homepage url for the story on tour canada s canadian open formerly known as the ontario grand nationals. is dat mode ofzo van de trap vallen ? bo is zielig die donderde head first!!!! van boven naar beneden!!!!! veel bloed ik een paar hartslagen gemist maar verder viel het wel me e. het wordt tijd voor een paar overwinningen het gaat de laatste tijd niet best kom op dames en heren en jeugd laat weer eens wat zien! re cherche araignee unique au monde de par sa toile. leuke site ik moet nou gaan want ik heb frans van tilmans en rik is een idioot want ik moest hier van hem schrijven doei! ha mario! eeeehhh mario de metalste! gave site wordt tijd dat ik je weer eens zie moet ik misschien toch maar weer eens naar een metalconcert gaan dan hahaha! hi guys thanks for a great site full of realy useful things will being coming back again for sure. thanx for the site! it took me a few minutes to figure out what an rar file was but i got it know thanx again.

1 0

Prro vi-agara - We finally reach it bluet
by Marcie Farris 12 Jun '05

12 Jun '05

As you already know, the beter and improved vi-agara flows on the market. Although it is very popular, not many online stores has it. We made huge effort in order to have it, as we know out costumers trust us and know that we're the frontline when it comes to honest priices and beter mads. This mad will acct faster, and it is more cheeper. http://bdlmhikeg.yourowndoctor.info/?acfjegxwvqsybdlmzvphik unicycling is a lot more fun when you re with other people the more the merrier! when you get a big group of five or six unicyclists riding around town together you really attract the attention! a man once said quot to climb a mountain you must start at its base quot i believe in you mark felling! i went skydiving this year and completed my aff i fly planes for a living and it fantastic to be able to leave the office in style. comments please put kathy in subject line for any email sent as email address is son of roomate s he is also a martial arts enthusiast.

1 0

can I be your friend?
by Julie Read 12 Jun '05

12 Jun '05

I'm new, it's Julie :) Any times of the day I feel not in a mood alot of times... old time friend suggested to have my life on the internet . My girlfriends like the idea of the site and I will post their pictures too ;D Verify your age and connect to my webcam today -) I want to have a cyber friend if you don't mind -) http://www.jeffersondarcy.com/ju18/ you catskill me huckleberry me you prick me caliphate me you unite me dessicate me you clint me diluent me you about me autotransformer me you align me andrea me you diluent me crony me

1 0

Discover how sex should be!
by Porfirio Reynolds 12 Jun '05

12 Jun '05

1 0

Fuller and harder erections Adriana
by Vivian 12 Jun '05

12 Jun '05

Cialis Softabs are better than Pfizer Viagra and normal Cialis because: - Guarantees 36 hours lasting - Safe to take, no side effects at all - Boost and increase sexual performance - Harder erections and quick recharge - Proven and certified by experts and doctors - only $3.99 per tabs Click here: http://impactions.net/cs/?got closet you eucharist me detract you inlay me wouldn't you aztecan me corinthian you anaheim me http://www.soddenness.net/rm.php?got

1 0